Product Information
PAROXETINE CR 12.5 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.4918 per EA under NDC 60505131603. Its NADAC has been published 328 times since May 13, 2020.
FDA first approved this application on Feb 16, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Apotex Corp.NDC
60505131603
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020936FDA Approved
2/16/1999
TE Code
AB
On Market Since
8/9/2019
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE CR 12.5 MG TABLET has been published 328 times since May 13, 2020, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4918 per EA |
|---|---|
| All-time high | $1.7329 (Jun 10, 2020) |
| All-time low | $0.4365 (Jul 23, 2025) |
| 52-week high | $0.5254 |
| 52-week low | $0.4433 |
| Median price | $0.8189 |
| Average price | $0.8088 |
| Largest weekly change | +48.4% (May 19, 2021) |
| Weeks tracked | 328 |
| Tracking since | May 13, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAROXETINE CR 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE CR 12.5 MG TABLET, manufactured by Apotex Corp., is $0.4918 per EA (NDC 60505131603), effective Aug 19, 2026.
How has the price of PAROXETINE CR 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE CR 12.5 MG TABLET has declined 69.8%. It has been tracked across 328 weekly CMS publications since May 13, 2020.
What are the highest and lowest recorded NADAC prices for PAROXETINE CR 12.5 MG TABLET?
Since May 13, 2020, the NADAC for PAROXETINE CR 12.5 MG TABLET has ranged from a low of $0.4365 (Jul 23, 2025) to a high of $1.7329 (Jun 10, 2020), with a median of $0.8189 per EA.
Are there cheaper alternatives to PAROXETINE CR 12.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PAROXETINE CR 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PAROXETINE CR 12.5 MG TABLET?
PAROXETINE CR 12.5 MG TABLET (NDC 60505131603) is labeled by Apotex Corp., and CMS classifies it as a generic product.